ActivCell Group

ActivCell Group is actively engaged in the development and production of cold plasma treatment pens. Its products have received Class 2a approval (CE-Notified-Body-No.0297) under the EU Medical Device Regulation 2017/745 (MDR) and can be used for skin and wound treatment in human medicine.